Crohn's Disease

🧠 Standard of Care

Crohn's Disease is a type of Inflammatory Bowel Disease (IBD) that causes chronic inflammation of the gastrointestinal (GI) tract. Unlike Ulcerative Colitis, which affects only the colon, Crohn's can affect any part of the GI tract from the mouth to the anus, often in "skip lesions."

• Gastroenterology Care: Regular monitoring through colonoscopy, endoscopy, and non-invasive markers (like fecal calprotectin) to ensure mucosal healing.
• Diet and Nutrition: While diet doesn't cause Crohn's, specific diets (like the Crohn's Disease Exclusion Diet) can reduce symptoms and support healing during flare-ups.
• Multidisciplinary Support: Management often requires dietitians, surgeons, and mental health professionals due to the significant impact on quality of life.

💊 Medical Therapies

The goal of medical treatment is to reduce the inflammation that triggers signs and symptoms, ultimately leading to long-term remission.

Corticosteroids

Medications like prednisone or budesonide are used for short-term control of moderate-to-severe flare-ups. They are not recommended for long-term use due to significant side effects.

Immunomodulators

Drugs like azathioprine or methotrexate reduce inflammation by broadly suppressing the immune system's response.

Biologics

These target specific proteins created by the immune system that cause inflammation. Classes include Anti-TNF drugs (Infliximab, Adalimumab), Integrin blockers (Vedolizumab), and Interleukin inhibitors (Ustekinumab, Risankizumab).

🏥 Surgical Interventions

Despite best medical therapies, up to 70% of people with Crohn's disease will eventually require surgery during their lifetime to remove damaged portions of the digestive tract, close fistulas, or drain abscesses.

Surgery is not a cure for Crohn's disease; the inflammation frequently returns near the surgical site. Thus, medication is typically resumed post-surgery to prevent recurrence.

🔬 Active Clinical Trials

Clinical trials are exploring novel targets, including the microbiome and specific immune pathways. Here are some live trials actively recruiting participants:

• NCT06890637 (All India Institute of Medical Sciences): The BOOST-CD Trial, a factorial randomized controlled trial evaluating the efficacy of microbiome manipulation strategies (Fecal Microbial Transplant or Crohn's Disease Exclusion Diet) alongside advanced biologics.
• NCT06274554 (Weill Medical College): The FUN-CD Trial, testing whether adding anti-fungal therapy (Fluconazole) to IL-23 therapy improves the response rate in Crohn's Disease.
• NCT06065228 (Children's National Research Institute): Developing therapeutic endpoints specifically for Pediatric IBD conditions.

⚠️ Complications & Extraintestinal Manifestations

Crohn's Disease is a systemic inflammatory condition, meaning its effects are not limited to the digestive tract.

• Strictures and Bowel Obstruction: Chronic inflammation can cause the walls of the bowel to thicken with scar tissue, narrowing the passage and leading to blockages that require immediate medical or surgical intervention.
• Malnutrition and Anemia: Damage to the small intestine (where most nutrients are absorbed) can lead to severe deficiencies in Vitamin B12, iron, and D.
• Extraintestinal Symptoms: Up to 30% of patients experience inflammation in other parts of the body, most commonly causing joint pain (arthritis), eye inflammation (uveitis), and painful skin lesions (Erythema Nodosum).

❓ Patient FAQ

Q: What is a flare-up?
A: A flare-up is a period when symptoms of Crohn's disease (such as severe abdominal pain, diarrhea, fatigue, and weight loss) return and become active after a period of remission.

Q: Can stress cause Crohn's disease?
A: Stress does not cause Crohn's disease, but it can trigger or worsen symptom flare-ups in people who already have the condition.

Q: What is a fistula?
A: A fistula is an abnormal connection or tunnel between two body parts, such as between two loops of intestine or between the intestine and the skin. They are a common complication of severe, penetrating Crohn's disease.